Asia Pharmaceutical Regulatory Affairs Training Course: Practical Overview Of The Key Areas With Focus On India (ONLINE EVENT: February 25-27, 2025)
( MENAFN - GlobeNewsWire - Nasdaq) Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia Training Course" has been added to ResearchAndMarkets.com's offering.
Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade)
Hutchmed expects to record a gain of $477m from the deal and plans to invest the proceeds to develop its internal pipeline. See why I rate HCM stock a Hold.
Hosted on MSN23h
EMA Accepts GSK's Filing for Depemokimab in Two Respiratory Diseases
GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...